Profile data is unavailable for this security.
About the company
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
- Revenue in EUR (TTM)19.47bn
- Net income in EUR483.59m
- Incorporated2006
- Employees117.13k
- LocationFresenius Medical Care AGElse-Kroener-Strasse 1BAD HOMBURG VOR DER HOHE 61352GermanyDEU
- Phone+49 61726090
- Fax+49 61 726092301
- Websitehttps://www.freseniusmedicalcare.com/
Holder | Shares | % Held |
---|---|---|
Dodge & Coxas of 31 Dec 2023 | 19.54m | 6.66% |
Pzena Investment Management LLCas of 24 Oct 2022 | 15.25m | 5.20% |
Harris Associates LPas of 26 Oct 2023 | 14.74m | 5.02% |
The Vanguard Group, Inc.as of 09 May 2024 | 7.38m | 2.51% |
Artisan Partners LPas of 31 Dec 2023 | 6.12m | 2.08% |
Barings (UK) Ltd.as of 31 Mar 2023 | 4.04m | 1.38% |
BlackRock Fund Advisorsas of 09 May 2024 | 3.63m | 1.24% |
FIL Investments Internationalas of 31 Mar 2024 | 3.22m | 1.10% |
Norges Bank Investment Managementas of 31 Dec 2023 | 2.96m | 1.01% |
Dimensional Fund Advisors LPas of 09 May 2024 | 2.23m | 0.76% |